{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:00:27Z","timestamp":1786993227759,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jpba.2022.115034","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:49:10Z","timestamp":1662637750000},"page":"115034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels"],"prefix":"10.1016","volume":"221","author":[{"given":"S.","family":"Fleury-Souverain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Maurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Guillarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rudaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bonnabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115034_bib1","first-page":"1236","article-title":"Re-evaluation of urine mutagenicity of pharmacy personnel exposed to antineoplastic agents","volume":"43","author":"Connor","year":"1986","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.jpba.2022.115034_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00002820-199804000-00001","article-title":"Nurses' and pharmacists' exposure to antineoplastic drugs: findings from industrial hygiene scans and urine mutagenicity tests","volume":"21","author":"Labuhn","year":"1998","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.jpba.2022.115034_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-1218(95)90086-1","article-title":"DNA damage in nurses handling antineoplastic agents","volume":"342","author":"Fuchs","year":"1995","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jpba.2022.115034_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/10773525.2015.1123380","article-title":"Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis","volume":"22","author":"Zare Sakhvidi","year":"2016","journal-title":"Int. J. Occup. Environ. Health"},{"key":"10.1016\/j.jpba.2022.115034_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mrgentox.2006.10.014","article-title":"Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs","volume":"628","author":"Cavallo","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jpba.2022.115034_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1539\/joh.12-0038-OA","article-title":"Biological effect monitoring in peripheral blood lymphocytes from subjects occupationally exposed to antineoplastic drugs: assessment of micronuclei frequency","volume":"54","author":"Villarini","year":"2012","journal-title":"J. Occup. Health"},{"key":"10.1016\/j.jpba.2022.115034_bib7","first-page":"5","article-title":"Uptake of antineoplastic agents in pharmacy and hospital personnel","volume":"76","author":"Pethran","year":"2003","journal-title":"Part I: Monit. Urin. Conc., Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.jpba.2022.115034_bib8","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/rcm.1642","article-title":"Trace determination of anthracyclines in urine: a new high-performance liquid chromatography\/tandem mass spectrometry method for assessing exposure of hospital personnel","volume":"18","author":"Sottani","year":"2004","journal-title":"Rapid. Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2022.115034_bib9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/15459624.2016.1165912","article-title":"Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations","volume":"13","author":"Connor","year":"2016","journal-title":"J. Occup. Environ. Hyg."},{"key":"10.1016\/j.jpba.2022.115034_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/15459624.2016.1237026","article-title":"A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs","volume":"14","author":"Kibby","year":"2017","journal-title":"J. Occup. Environ. Hyg."},{"key":"10.1016\/j.jpba.2022.115034_bib11","unstructured":"The United States Pharmacopeial Convention. Hazardous drugs\u2014handling in healthcare settings (General information chapter 800). 41th edn. The United States Pharmacopeia, 2018."},{"key":"10.1016\/j.jpba.2022.115034_bib12","unstructured":"European Biosafety Network, https:\/\/www.europeanbiosafetynetwork.eu\/wp-content\/uploads\/2019\/03\/Amendments-to-CMD3-and-implications.pdf 2019 (accessed 26 August 2022)."},{"key":"10.1016\/j.jpba.2022.115034_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/mas.20159","article-title":"The application of inductively coupled plasma mass spectrometry in clinical pharmacological oncology research","volume":"27","author":"Brouwers","year":"2008","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.jpba.2022.115034_bib14","first-page":"589","article-title":"Analytical strategies for assessing occupational exposure to antineoplastic drugs in healthcare workplaces","volume":"69","author":"Dugheri","year":"2018","journal-title":"Med. Pr."},{"key":"10.1016\/j.jpba.2022.115034_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/19338244.2013.763757","article-title":"Association of surface contamination by antineoplastic drugs with different working conditions in hospital pharmacies","volume":"69","author":"Odraska","year":"2014","journal-title":"Arch. Environ. Occup. Health"},{"key":"10.1016\/j.jpba.2022.115034_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00685736","article-title":"Long-term platinum excretion in patients treated with cisplatin","volume":"36","author":"Schierl","year":"1995","journal-title":"Cancer Chemother., Pharm."},{"key":"10.1016\/j.jpba.2022.115034_bib17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/ph14080754","article-title":"An improved LC-MS\/MS method for the analysis of thirteen cytostatics on workplace surfaces","volume":"14","author":"Portilha-Cunha","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2022.115034_bib18","first-page":"150","article-title":"Developing a fast ultra-high-performance liquid chromatography-tandem mass spectrometry method for high-throughput surface contamination monitoringof 26 antineoplastic drugs","volume":"8","author":"Dugheri","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2022.115034_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15459624.2021.2000617","article-title":"A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling","volume":"19","author":"K\u00e5redal","year":"2022","journal-title":"J. Occup. Environ. Hyg."},{"key":"10.1016\/j.jpba.2022.115034_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpba.2018.11.014","article-title":"Computer-assisted UHPLC-MS method development and optimization for the determination of 24 antineoplastic drugs used in hospital pharmacy","volume":"164","author":"Guichard","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2022.115034_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/dta.1827","article-title":"Antineoplastic drugs determination by HPLC-HRMS(n) to monitor occupational exposure","volume":"8","author":"Dal Bello","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2022.115034_bib22","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1007\/s00216-015-8868-y","article-title":"A surface wipe sampling and LC-MS\/MS method for the simultaneous detection of six antineoplastic drugs commonly handled by healthcare workers","volume":"407","author":"Jeronimo","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2022.115034_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ejhpharm-2019-001983","article-title":"Wipe-sampling procedure optimisation for the determination of 23 antineoplastic drugs used in the hospital pharmacy","volume":"28","author":"Guichard","year":"2021","journal-title":"Eur. J. Hosp. Pharm."},{"key":"10.1016\/j.jpba.2022.115034_bib24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/rcm.1030","article-title":"Electrospray ionization mass spectrometry coupled to liquid chromatography for detection of cisplatin and its hydrated complexes","volume":"17","author":"Cui","year":"2003","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2022.115034_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.talanta.2017.06.002","article-title":"Bocxlaer, Zwitterionic hydrophilic interaction liquid chromatography-tandem mass spectrometry with HybridSPE-precipitation for the determination of intact cisplatin in human plasma","volume":"174","author":"Xie","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2022.115034_bib26","unstructured":"European Chemicals Agency, Helsinki, Finland https:\/\/echa.europa.eu\/fr\/brief-profile\/-\/briefprofile\/100.155.403 (accessed 15 July 2022)."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:21:57Z","timestamp":1760001717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522004551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":26,"alternative-id":["S0731708522004551"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115034","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115034"}}